• Contact Us

Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!

• Annual Meeting
  • Register
  • Sponsor & Exhibit
  • Future Annual Meetings
  • Annual Meeting Archives

  • Program
    • Workshops
    • Venue Maps

  • Abstracts
    • Present
    • Awards
    • Topics
• Membership
  • Video Library
    • Annual Meeting
    • Cancer
    • Career Skills
    • Gene Editing
    • Patients and Clinicians
    • Regulatory
    • Viral Vectors

  • Become a Member
  • Economy-Based Rates
  • Awards
  • Membership Directory
  • Scientific Committees
  • Standing Committees

  • My Profile
  • Career Center
  • ASGCT Abstracts
    • Abstract Submission Windows
  • Volunteer
• Events
  • Advancing Gene and Cell Therapies for Cancer
    • Registration
    • Program
    • Abstracts
    • Speaker + Attendee Resources
  • Empowering Patients 2025: A Cell and Gene Therapies Summit

  • Around the World: Advanced Therapy Medicinal Production in South America
  • Class Considerations on Immunogenicity for AAV GT Products: Assessing Current Practice + New Data
  • Molecular Therapy Presents: Extracellular Vesicles
  • Professional Development Cafés
    • Dec. 13: Focused Ultrasound: Cutting-Edge Applications in Cell and Gene Therapies
  • Non-ASGCT Events

  • Breakthroughs in Muscular Dystrophy
    • Registration
    • Abstracts
    • Program
    • Speaker + Attendee Resources
    • Sponsorship
• Awards
  • Annual Meeting Awards
    • Outstanding Achievement Award
    • Outstanding New Investigator Awards
    • George Stamatoyannopoulos Mentorship Award
    • Award for Excellence in Advancing Diversity, Equity, and Inclusion
    • Exemplary Service Award

  • Career Development Awards
  • Congressional Policy Fellowship

  • Underrepresented Populations in Gene and Cell Therapy
  • Mavis Agbandje-McKenna Scholarship and Fund
• Outreach
  • Clinical Trials Finder
  • Community Quick Takes
    • Informed Consent
    • State of the Field Highlights + Approvals for CGT in 2023
    • Access to Approved Cell and Gene Therapies
    • Genetic Testing and Clinical Trial Eligibility
  • Diversity, Equity, and Inclusion
    • Biotech Discovery Labs Program

  • Patient Education: Gene Therapy 101
    • Gene Therapy Basics
    • Gene Therapy Approaches
    • Clinical Trials Process
    • Vectors 101
    • Gene Editing
  • Global Outreach

  • Patient Education: Condition Treatments
    • Beta Thalassemia & Other Blood Disorders
    • CALD and MLD
    • Spinal Muscular Atrophy
    • CAR-T Basics
    • Hemophilia
• Publications
  • ASGCT Blog
  • The Patient Press
    • October 2024
  • The Vector
  • Quarterly Gene, Cell, and RNA Therapy Landscape Report

  • ASGCT Podcast Network
    • Giants of Gene Therapy
    • The Issue
    • The Molecular Therapy Podcast
  • The Advocate
    • Subscribe to The Advocate

  • Molecular Therapy Family
    • Molecular Therapy Presents Extracellular Vesicles
    • Cell Press Webinar: Advances in Viral Vector Gene Delivery for CT Biomanufacturing
    • Molecular Therapy
    • MT Methods & Clinical Development
    • MT Nucleic Acids
    • MT Oncology
• Advocacy
  • Events and Opportunities
    • Policy Summit
    • ASGCT-FDA Liaison Meeting
    • Cell + Gene Therapy Science Series
    • Congressional Policy Fellowship
    • FDA & ASGCT: Immune Responses to AAV Vectors

  • Policy Priorities
    • Patient Access Overview
    • Regulatory Policy
    • Research Funding

  • The Advocate
    • Subscribe to The Advocate
  • Policy Statements & Letters
• About
  • Leadership
    • Board of Directors
    • Scientific Committees
    • Standing Committees
    • Staff
  • Work at ASGCT
    • Development Coordinator
    • Education Coordinator
    • Meeting Planner

  • Media
  • Our Culture
  • Strategic Plan
  • Meeting Code of Conduct
  • Terms and Conditions

  • Mission & Vision
    • Bylaws
  • Support ASGCT
    • Annual Meeting Support
    • Advertise in ASGCT Publications
    • Digital Programs
    • Giving
    • Year-Round Support

The Advocate

ASGCT's policy and advocacy-focused newsletter.

Subscribe to The Advocate

Receive The Advocate in your inbox every month to stay up to date on ASGCT's policy and advocacy-related actions to advance gene and cell therapies! 

Subscribe

Read Archived Issues

September 2024

In this issue: Read our recent comments to FDA and CMS, check out our latest Community Quick Takes module on genetic testing and clinical trial access, stay up to date on policy news, and more.

Read the issue